Mm, paywalled for a month I suppose, then search ‘Japan corporate trial’ or so from the top of FT.com which does permit a browse. They have a podcast if you want to check those legs before ‘giving up’ CBD for February or breakfasting light at the library or sending to the reference desk for a nice corroborative-or-nay packet.
I’ve been following the news on this in Japanese anyway, the basic information isn’t new to me, I was kind of curious what FT had to say is all.
This topic was automatically closed after 5 days. New replies are no longer allowed.
